• About PRIME
  • Advertise With Us
  • Contact Us
Advertisement
PRIME Journal
  • Home
  • Digital Issue
  • Categories
    • Energy Based Devices
    • Minimally Invasive
    • Skincare
    • Injectables
    • Dermatology
    • Anti-ageing
    • Body Contouring
    • Invasive treatments
  • Features
    • Case Study
    • PRIME People
    • Company Profile
    • Industry Analysis
    • Sponsored Features
  • News
  • Sign Up
  • Login

Select Page

Advertisement

PRIME July/August 2024 issue

Digital Magazine, News

Share:

PreviousAllergan Aesthetics and University Lab Partners Team Up for the Golden Ticket Pitch Competition
NextPRIME September/October 2024 issue

Related Posts

New indications for SkinCeuticals H.A. Intensifier now clinically proven for eyes and lips

New indications for SkinCeuticals H.A. Intensifier now clinically proven for eyes and lips

January 29, 2019

FDA Approve Bayer’s Finacea® (azelaic acid) Foam, 15% for the Topical Treatment of Rosacea

FDA Approve Bayer’s Finacea® (azelaic acid) Foam, 15% for the Topical Treatment of Rosacea

August 3, 2015

Allergan acquires medical dermatology and aesthetic medicine company Anterios to expand neurotoxin pipeline

Allergan acquires medical dermatology and aesthetic medicine company Anterios to expand neurotoxin pipeline

January 13, 2016

Ingenious Beauty Proves Up To 85% Wrinkle Reduction in UK’S Largest Collagen Supplement Clinical Trial

Ingenious Beauty Proves Up To 85% Wrinkle Reduction in UK’S Largest Collagen Supplement Clinical Trial

May 14, 2020

Search

Login Status

Forgot?  Register

May/June 2026 Issue

Advertisement

Upcoming Events

No events are found.

All events

Categories

  • Injectables
  • Dermatology
  • Anti-ageing
  • Body Contouring
  • Invasive treatments
  • Case Study
  • Practice Management
  • Sponsored
  • Industry Insider
  • Company Profile
  • PRIME People
  • Meeting reviews
  • Commentary

Designed by Elegant Themes | Powered by WordPress

  • Contact Us
  • Editorial Board
  • Terms & Conditions
  • Privacy Policy